Kaspers, S; Famulla, S; Pieber, TR; Eilbracht, J; Neubacher, D;
Soleymanlou, N; Broedl, UC.
Empagliflozin decreases glucose exposure and variability in patients
with type 1 diabetes: continuous glucose monitoring data (EASE-1).
Diabetologia. 2015; 58(Suppl 1 ):S367-S367.-51st Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN.
[Poster]
Web of Science